Vitrolife AB banner

Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 94.5 SEK 2.66%
Market Cap: kr12.8B

Wall Street
Price Targets

VITR Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VITR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VITR is 163.2 SEK with a low forecast of 101 SEK and a high forecast of 225.75 SEK.

Lowest
Price Target
101 SEK
7% Upside
Average
Price Target
163.2 SEK
73% Upside
Highest
Price Target
225.75 SEK
139% Upside
Vitrolife AB Competitors:
Price Targets
TARA
Protara Therapeutics Inc
356% Upside
FLEX
Flex Ltd
26% Upside
KRNY
Kearny Financial Corp
23% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
21% Upside

Revenue
Forecast

18% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
18% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Vitrolife AB's revenue is 18%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

21% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
21% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 14 years the compound annual growth rate for Vitrolife AB's operating income is 21%. The projected CAGR for the next 3 years is 20%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VITR's stock price target?
Price Target
163.2 SEK

According to Wall Street analysts, the average 1-year price target for VITR is 163.2 SEK with a low forecast of 101 SEK and a high forecast of 225.75 SEK.

What is Vitrolife AB's Revenue forecast?
Projected CAGR
6%

For the last 14 years the compound annual growth rate for Vitrolife AB's revenue is 18%. The projected CAGR for the next 3 years is 6%.

What is Vitrolife AB's Operating Income forecast?
Projected CAGR
20%

For the last 14 years the compound annual growth rate for Vitrolife AB's operating income is 21%. The projected CAGR for the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett